Iron Mountain Incorporated (NYSE:IRM) Goldman Sachs Communacopia + Technology Conference September 10, 2024 11:50 AM ET Company Participants Barry Hytinen - CFO Conference Call Participants George Tong - Goldman Sachs Santiago Suinaga - Infrastructure Masons George Tong Let's go ahead and get started. Good morning, everyone, and welcome. I'm George Tong, I'm the Business Services Analyst at Goldman. And I'm really pleased to be joined by Barry Hytinen, CFO of Iron Mountain. Barry, thank you for joining us. ...

Summary of Datadog Inc. Conference Call Company Overview - **Company**: Datadog Inc. (NASDAQ: DDOG) - **Event**: Goldman Sachs Communacopia + Technology Conference Call - **Date**: September 10, 2024 Key Points Industry and Company Vision - Datadog is positioned as a product-led growth company focused on DevOps, aiming to be the primary platform for monitoring and remediation of mission-critical modern applications [3][5] - The company aspires to be similar to other platform companies like ServiceNow, Atlassian, and Salesforce, emphasizing ease of use and continuous innovation [5] Operational Goals and Strategies - The company plans to enhance its platform by innovating and adding more functionalities, including service management and LLM monitoring [7][8] - Hiring and educating talent is crucial for operational success, alongside expanding go-to-market strategies geographically and through centralized selling [7][8] Business Trends - Recent trends indicate that larger enterprises are recovering and investing in digital projects, while SMBs show stability but less growth [10][12] - Customers are increasingly signing longer-term contracts due to confidence in their capacity needs and Datadog's growing market share [15] Impact of Generative AI - Datadog benefits from the modernization of applications and the deployment of AI technologies, which stimulate investment cycles [17][18] - Currently, 4% of ARR is attributed to companies involved in AI tools, but most customers are still in the testing phase with limited production workloads [27][29] Market Dynamics - The company is experiencing a trend of tool consolidation among customers, leading to increased demand for multi-product adoption within the Datadog platform [41] - Datadog's growth is driven by new customer acquisition, increased product adoption, and market share expansion [41] Future Growth Opportunities - The core infrastructure business has significant growth potential as enterprises continue to migrate to the cloud and modernize their application stacks [45] - Datadog is optimistic about capturing market share from competitors, especially as other solutions lag in investment and innovation [53] Financial Metrics and Customer Engagement - The company tracks million-dollar customers as a key performance indicator, reflecting health in cross-selling and growth [56] - Datadog is focused on enhancing productivity through AI, aiming to improve operational efficiency without reducing headcount [62][66] Acquisition Strategy - Datadog evaluates potential acquisitions based on their alignment with the product roadmap and the ability to integrate into the existing platform [71] Additional Insights - The company emphasizes a disciplined approach to acquisitions, focusing on teams that can continue to innovate within Datadog's framework [71] - Internal use of Generative AI has shown promising results, particularly in sales and marketing, enhancing productivity [59][66] This summary encapsulates the key insights and strategic directions discussed during the conference call, highlighting Datadog's focus on innovation, market positioning, and growth opportunities in the evolving tech landscape.

Gilead Sciences, Inc. (NASDAQ:GILD) Baird Global Healthcare Conference September 10, 2024 10:50 PM ET Company Participants Johanna Mercier - Chief Commercial Officer Conference Call Participants Brian Skorney - Baird Brian Skorney [Starts abruptly] biotech analysts here. [Technical Difficulty] to have presenting with us next, Gilead Sciences. Thanks for coming today. We really appreciate it. Maybe just to kick things off, I'll kind of ask the general question to give a broad overview of what Gilead does and ...

Bank of America Corporation (NYSE:BAC) Barclays 22nd Annual Global Financial Services Conference September 10, 2024 1:05 PM ET Company Participants Brian Moynihan - Chairman, CEO & President Conference Call Participants Jason Goldberg - Managing Director, Barclays Jason Goldberg Thanks, everybody. Thanks again for joining us today at this conference. It is my great, great pleasure to introduce Brian Moynihan, Chairman and CEO of Bank of America. And you guys are always going to talk about BFA, but I'd like ...

Alphabet Inc. (NASDAQ:GOOG) Goldman Sachs 2024 Communacopia and Technology Conference September 10, 2024 4:05 PM ET Company Participants Thomas Kurian – CEO, Google Cloud Conference Call Participants Eric Sheridan - Goldman Sachs Eric Sheridan All right. I know people are still finding their seats, but in the interest of time, let's -- we'll get started on our next session. I'm going to start with a safe harbor. I'm going to introduce Thomas Kurian, who's going to join me up on stage, walk through a slide p ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) TD Cowen 9th Annual FutureHealth Conference September 10, 2024 4:10 PM ET Company Participants Ramita Tandon - Chief Clinical Trial Officer Conference Call Participants Charles Rhyee - TD Cowen Charles Rhyee All right. I think, we're going to get started with our last session of the day, and thanks everyone for sticking around here. So, in June of '22, Walgreens launched its clinical trial business, which utilizes Walgreens national retail pharmacy footprint to pr ...

Microsoft Corporation (NASDAQ:MSFT) Goldman Sachs Communacopia + Technology Conference September 10, 2024 3:25 PM ET Company Participants Kevin Scott - CTO Microsoft Conference Call Participants Kash Rangan - Goldman Sachs Kash Rangan Excellent, excellent. Thank you very much. A real delight to be able to host the CTO of Microsoft, Kevin Scott, as our next speaker. I'm sure the discussion is going to be fascinating. I'm told that, Kevin, this is -- this maybe the first time ever at an investor conference, a ...

Novavax, Inc. (NASDAQ:NVAX) Baird 2024 Global Healthcare Conference September 10, 2024 3:10 PM ET Unidentified Company Representative I'd like to thank you all for joining us for Novavax Corporate presentation certainly for Baird for having us here again this year. This is always such a great forum and it coincides with the beginning of the vaccination season for COVID vaccines. We're going to talk a lot about our technology today, but really important announcement just very recently with the authorization ...

Etsy, Inc. (NASDAQ:ETSY) Goldman Sachs Communacopia + Technology Conference September 10, 2024 11:50 AM ET Company Participants Rachel Glaser - CFO Josh Silverman - CEO Conference Call Participants Eric Sheridan - Goldman Sachs Eric Sheridan Okay. I know everyone is shuffling around, and we're moving around quickly between these sessions. So we're going to get started in the interest of time, even though it looks like plenty of people are still finding their seats. It's great to have Etsy here at the confer ...

Ford Motor Company (NYSE:F) Goldman Sachs Communacopia + Technology Conference September 10, 2024 1:50 PM ET Company Participants Navin Kumar - CFO of Ford Pro Conference Call Participants Mark Delaney - Goldman Sachs Mark Delaney Okay, great. Thank you everybody for joining. My name is Mark Delaney and I lead coverage of Ford for Goldman Sachs. I'm very pleased to have Navin Kumar, the CFO of Ford Pro with us today. Thanks for joining. Navin Kumar Thank you, Mark for the introduction. Good morning, everyo ...